–
Статьи в журналах
-
- 2022 VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
- Kulemzin Sergey V., Sergeeva Maria V., Baranov Konstantin O., Gorchakov Andrey A., Guselnikov Sergey V., Belovezhets Tatyana N., Volkova Olga Yu, Najakshin Alexander M., Chikaev Nikolai A., Danilenko Daria M., Taranin Alexander V.
- в журнале Journal of Personalized Medicine, издательство MDPI (Basel, Switzerland), том 12, № 6, с. 895-895 DOI